Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

BACKGROUND: The presence of tumour-infiltrating lymphocytes (TILs) is associated with response to neoadjuvant chemotherapy among patients with triple-negative and HER2-positive breast cancer. However, the significance of TILs is less clear in luminal breast cancer. Here, we in postmenopausal patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Skriver, Signe Korsgaard, Jensen, Maj-Britt, Knoop, Ann Soegaard, Ejlertsen, Bent, Laenkholm, Anne-Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222485/
https://www.ncbi.nlm.nih.gov/pubmed/32410705
http://dx.doi.org/10.1186/s13058-020-01285-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222485/
https://www.ncbi.nlm.nih.gov/pubmed/32410705
http://dx.doi.org/10.1186/s13058-020-01285-8

Ejemplares similares